hi

i'm brunch require

for some time

the following to sabine challenges to find an effective safeway

two three joint pain in the real patients

a single aspect

her and said could produce complete renal failure

now positions of all disciplines

a become aware of the and here wrists

a pain medication

with over one hundred million patience in the united states

with me again

a team of physicians by a physicist in by always in years

set out on the mission to develop technology

that would be effective and safe

can't really enjoyed in muscle pay

the result of that

was a digital device

digital madison device

that have both sensory

and therapeutic capabilities

and

the results for the patients were getting

very good results

pain was reduced

well ability was increased and performance was enhanced

and then we needed to validate

that what we were scene was

not placebo effect so

in medical study was commissioned

and doctor can but when our scientific adviser

and data can klugey

our principal investigator developed and executed the study

hello i'm can collegian admin an emergency madison position for over thirty years

i think what joint pain from sports injuries another causes can do it when individuals

quality of life and performance

it's well known that pain pills injections at a given joint surgery has its limitations

and rests

as it became more familiar with new digital technology for joint and muscle pain i

was also very intrigued with the clinical potential it offered

and i look forward to participating in the clinical study design by top to bottom

five my name is can blackman my background is an academic pharmacology rife talk conducted

research in both general in clinical pharmacology and canonical form of cocaine addicts for over

three decades

much of mikes research experience pertain to the design an execution of phase one and

phase two clinical trials of new drugs

however many of those studies have been broadly similar to this pilot study of the

clinical effectiveness of the willow m d

sixty nine patients with chronic need pain were randomly allocated to one of four treatment

groups

with approximately seventeen patients per group

the study was completely blinded with one group treated with a fully operational device using

both thermal and photonic energies

a second group was treated with the device emitting only thermal kinetic energy

of for group was treated with the device configured only emit photonic energy and the

fourth group was treated with a complete sham device

several parameters for example number of steps climbed need circumference as pain range during collection

and function angle achieved prior to paint perception were assessed

the assessments occurred immediately prior to treatment and immediately after application of a twenty five

minute treatment

and analysis of variance with the tukey multiple comparisons procedure was used for comparing treatment

results

the fully or partially activated device was

statistically superior to the sham device impatience chronically

results suggest this device may have benefits locations are partly name and the larger more

robust studies of the device are clearly more